Back to search
FDAFDA · Food and drugs·Recall number Z-2156-2025

Medline Convenience Kits, containing BD ChloraPrep Clear - 1mL Applicator, labeled as: C-SECTION PREP, REF DYNJ32702B

Published July 30, 2025 · Recall initiated: June 12, 2025

Summary

FDA records medical device Class II recall Z-2156-2025, published July 30, 2025 and initiated June 12, 2025. Recalling firm: MEDLINE INDUSTRIES, LP - Northfield; Status: Ongoing; Reported quantity: 48 units; Lot: UDI/DI 10193489431070 (EA), 40193489431071 (CASE), Lot Numbers: 24EBR761. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Affected convenience kits contain BD ChloraPrep Clear - 1 mL Applicators, which were recalled by BD due to potential to exhibit an open seal on its packaging. This may constitute a breach to sterility, which may in turn lead to the infection related harms for the patient.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
MEDLINE INDUSTRIES, LP - Northfield
Distributor
Distributed domestically to California, Florida, Pennsylvania, and Texas. No international distribution.
Lot
UDI/DI 10193489431070 (EA), 40193489431071 (CASE), Lot Numbers: 24EBR761
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Medline Convenience Kits, containing BD ChloraPrep Clear - 1mL Applicator, labeled as: C-SECTION PREP, REF DYNJ32702B recalled?

Yes. FDA published recall Z-2156-2025 on July 30, 2025. Reported hazard: Affected convenience kits contain BD ChloraPrep Clear - 1 mL Applicators, which were recalled by BD due to potential to exhibit an open seal on its packaging. This may constitute a breach to sterility, which may in turn lead to the infection related harms for the patient.

What should I do if I have this product?

Voluntary: Firm initiated · Letter